Evolent Health, Inc. (EVH) — Analyst outlook / Analyst consensus target is. Based on 29 analyst ratings, the consensus is bullish — 23 Buy, 6 Hold.
The consensus price target is $6.38 (low: $3.50, high: $10.00), representing an upside of 154.2% from the current price $2.51.
Analysts estimate Earnings Per Share (EPS) of $0.71 and revenue of $2.56B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.81 vs est $0.71 (missed -214.6%). 2025: actual $-5.07 vs est $0.06 (missed -7990.7%). Analyst accuracy: 0%.
EVH Stock — 12-Month Price Forecast
$6.38
▲ +154.18% Upside
Average Price Target
Based on 29 Wall Street analysts offering 12-month price targets for Evolent Health, Inc., the average price target is $6.38, with a high forecast of $10.00, and a low forecast of $3.50.
The average price target represents a +154.18% change from the last price of $2.51.
Highest Price Target
$10.00
Average Price Target
$6.38
Lowest Price Target
$3.50
EVH Analyst Ratings
Buy
Based on 29 analysts giving stock ratings to Evolent Health, Inc. in the past 3 months
EPS Estimates — EVH
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.81
vs Est $0.71
▼ 187.2% off
2025
Actual –$5.07
vs Est $0.06
▼ 101.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect the company to turn profitable.
Revenue Estimates — EVH
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $2.555B
vs Est $2.559B
▼ 0.2% off
2025
Actual $1.876B
vs Est $1.876B
▲ 0.0% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
